Market Overview

7 Largest Price Target Changes For Friday

Share:

 

  • D.A. Davidson raised the price target for Cyberark Software Ltd (NASDAQ: CYBR) from $42 to $51. Cyberark Software shares rose 4.02 percent to $52.53 in pre-market trading.
  • BTIG slashed T2 Biosystems Inc (NASDAQ: TTOO) price target from $12 to $4. T2 Biosystems shares closed at $7.61 on Wednesday.
  • JPMorgan lowered the price target on Juno Therapeutics Inc (NASDAQ: JUNO) from $63 to $39. Juno Therapeutics shares dropped 24.64 percent to $30.76 in pre-market trading.
  • Citi increased the price target for AT&T Inc. (NYSE: T) from $42 to $46. AT&T shares fell 0.12 percent to $42.25 in pre-market trading.
  • Nomura cut the price target on AVG Technologies NV (NYSE: AVG) from $30 to $25. AVG shares closed at $24.58 on Wednesday.
  • JP Morgan lowered Humana Inc (NYSE: HUM) price target from $196 to $150. Humana shares declined 1.44 percent to $160.40 in pre-market trading.
  • Goldman Sachs raised the price target for HCP, Inc. (NYSE: HCP) from $26 to $36. HCP shares rose 0.46 percent to $35.04 in pre-market trading.

Latest Ratings for CYBR

DateFirmActionFromTo
Sep 2020BarclaysUpgradesEqual-WeightOverweight
Aug 2020Morgan StanleyMaintainsOverweight
Jul 2020Morgan StanleyMaintainsOverweight

View More Analyst Ratings for CYBR
View the Latest Analyst Ratings

 

Related Articles (CYBR + TTOO)

View Comments and Join the Discussion!

Posted-In: Price Target ChangesPrice Target Analyst Ratings

Latest Ratings

StockFirmActionPT
OCXBTIGInitiates Coverage On5.0
GCMGWilliam BlairInitiates Coverage On
PDCraig-HallumInitiates Coverage On41.0
CAPLWells FargoDowngrades
MMPWells FargoDowngrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com